loader
Please Wait
Applying Filters...
Close
4

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Information, Expiry & Status of FDA Orange Book Patents covering Sitagliptin Phosphate

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MERCK SHARP DOHME (18)

02 MSD SUB MERCK (24)

03 ZYDUS LIFESCIENCES (3)

filter

01 7326708 (16)

02 8080580 (2)

03 8414921 (2)

04 9308204 (2)

05 9439901 (2)

06 10925871 (3)

07 7326708*PED (16)

08 8414921*PED (2)

filter

01 Y (18)

02 Blank (27)

filter

01 Y (25)

02 Blank (20)

filter

01 2026-04-11 (6)

02 2026-10-11 (6)

03 2026-11-24 (10)

04 2027-05-24 (10)

05 2028-07-21 (2)

06 2029-01-21 (2)

07 2030-07-13 (2)

08 2030-10-21 (4)

09 2035-02-25 (3)

URL Supplier Web Content
7326708
Y
Y
2026-04-11
U-1188
202343
METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-04-11
U-1188
202343
METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-04-11
U-1188
202343
METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-04-11
U-1188
202343
METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-04-11
U-1188
202343
METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-11-24
U-802
21995
METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-11-24
U-802
21995
METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-04-11
U-1188
202343
METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708
Y
Y
2026-11-24
U-802
21995
METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7326708*PED
2027-05-24
21995
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content